Literature DB >> 3614390

The M2 selective antagonist AF-DX 116 shows high affinity for muscarine receptors in bovine tracheal membranes.

A F Roffel, W G in't Hout, R A de Zeeuw, J Zaagsma.   

Abstract

We have characterized the muscarine receptors in bovine tracheal and left ventricular membranes using 3H-dexetimide/pirenzepine and 3H-dexetimide/AF-DX 116 competition studies. Pirenzepine exhibited low (M2) affinity binding to both preparations; Kd was 590 nM in left ventricle and 463 nM in trachea. AF-DX 116 exhibited high (M2) affinity binding to left ventricle (Kd = 95.6 nM); in tracheal membranes it bound with high (M2) affinity (Kd = 40.7 nM) to 74% of the receptors and with low (M3) affinity (Kd = 2.26 microM) to 26% of the receptors. It is concluded that bovine tracheal muscle membranes contain a heterogeneous population of muscarine binding sites, the majority having M2 (heart) subtype characteristics and being located on the smooth muscle membranes; a minority having M3 (exocrine gland) subtype characteristics and presumed to be located in submucosal glands. This is the first report of high affinity binding of AF-DX 116 to non-cardiac peripheral muscarine receptors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3614390     DOI: 10.1007/bf00169130

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  10 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Cardioselective profile of AF-DX 116, a muscarine M2 receptor antagonist.

Authors:  A Giachetti; R Micheletti; E Montagna
Journal:  Life Sci       Date:  1986-05-05       Impact factor: 5.037

3.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

4.  Purification and characterization of cardiac sarcolemma and sarcoplasmic reticulum from rat ventricle muscle.

Authors:  J Velema; J Zaagsma
Journal:  Arch Biochem Biophys       Date:  1981-12       Impact factor: 4.013

5.  Failure of gallamine and pancuronium to inhibit selectively (-)-[3H]quinuclidinyl benzilate binding in guinea-pig atria.

Authors:  L K Choo; E Leung; F Mitchelson
Journal:  Can J Physiol Pharmacol       Date:  1985-03       Impact factor: 2.273

6.  Pirenzepine distinguishes between different subclasses of muscarinic receptors.

Authors:  R Hammer; C P Berrie; N J Birdsall; A S Burgen; E C Hulme
Journal:  Nature       Date:  1980-01-03       Impact factor: 49.962

7.  Biochemical characteristics of muscarinic cholinoreceptors in swine tracheal smooth muscle.

Authors:  C M Yang; J M Farley; T M Dwyer
Journal:  J Auton Pharmacol       Date:  1986-03

8.  Binding profile of a novel cardioselective muscarine receptor antagonist, AF-DX 116, to membranes of peripheral tissues and brain in the rat.

Authors:  R Hammer; E Giraldo; G B Schiavi; E Monferini; H Ladinsky
Journal:  Life Sci       Date:  1986-05-05       Impact factor: 5.037

9.  Comparison of muscarinic receptor properties in hatched chick heart atrium and ventricle.

Authors:  S Sorota; L P Adam; A J Pappano
Journal:  J Pharmacol Exp Ther       Date:  1986-03       Impact factor: 4.030

10.  Characterization of the muscarinic receptor in human tracheal smooth muscle.

Authors:  C J van Koppen; J F Rodrigues de Miranda; A J Beld; M W Hermanussen; J W Lammers; C A van Ginneken
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-11       Impact factor: 3.000

  10 in total
  11 in total

1.  Human gastric mucosa expresses glandular M3 subtype of muscarinic receptors.

Authors:  A Pfeiffer; C Hanack; R Kopp; R Tacke; U Moser; E Mutschler; G Lambrecht; M Herawi
Journal:  Dig Dis Sci       Date:  1990-12       Impact factor: 3.199

2.  Characterization of the muscarinic receptor subtype involved in phosphoinositide metabolism in bovine tracheal smooth muscle.

Authors:  A F Roffel; H Meurs; C R Elzinga; J Zaagsma
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

3.  Functional and binding studies with muscarinic M2-subtype selective antagonists.

Authors:  S Lazareno; F F Roberts
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

Review 4.  Muscarinic receptor antagonists: effects on pulmonary function.

Authors:  Kalmia S Buels; Allison D Fryer
Journal:  Handb Exp Pharmacol       Date:  2012

5.  Role of the M2 muscarinic receptor pathway in lidocaine-induced potentiation of the relaxant response to atrial natriuretic peptide in bovine tracheal smooth muscle.

Authors:  Motonari Yunoki; Tsutomu Nakahara; Akiko Mitani; Kenji Sakamoto; Kunio Ishii
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2002-11-30       Impact factor: 3.000

6.  Selective inactivation of muscarinic M2 and M3 receptors in guinea-pig ileum and atria in vitro.

Authors:  R M Eglen; G C Harris
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

7.  Muscarinic receptor subtypes, beta-adrenoceptors and cAMP in the tracheal smooth muscle of conventional and double-muscled calves.

Authors:  E Roets; C Burvenich; M Roberts
Journal:  Vet Res Commun       Date:  1992       Impact factor: 2.459

8.  Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor.

Authors:  D B Jacoby; G J Gleich; A D Fryer
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

9.  Characterization of muscarinic receptors mediating release of epithelial derived relaxant factor (EpDRF) in guinea-pig isolated trachea.

Authors:  R M Eglen; G C Harris; M Taylor; J R Pfister; R L Whiting
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-07       Impact factor: 3.000

10.  Bile acids inhibit cholinergic constriction in proximal and peripheral airways from humans and rodents.

Authors:  Andreacarola Urso; Frank D'Ovidio; Dingbang Xu; Charles W Emala; Nigel W Bunnett; Jose F Perez-Zoghbi
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-12-04       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.